Cite

HARVARD Citation

    Clunie, G. et al. (2014). An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Annals of the rheumatic diseases. 73 (6), pp. 1273-1274. [Online]. 
  
Back to record